- Tytuł:
- Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis
- Autorzy:
-
Karolina Strzebonska
Mateusz Michał Blukacz
Mateusz T. Wasylewski
Maciej Polak
Bishal Gyawali
Marcin Waligora - Data publikacji:
- 2022
- Słowa kluczowe:
-
Ethics; Risk-benefit balance; Targeted therapy; Umbrella trial; Antineoplastic Agents; Humans; Medical Oncology; Neoplasms; Precision Medicine; 8 [4 (1 aminocyclobutyl)phenyl] 9 phenyl 1
2
4 triazolo[3
4 f][1
6]naphthyridin 3(2h) one; antineoplastic agent; binimetinib; capmatinib; ceritinib; erlotinib; selumetinib; sorafenib; antineoplastic agent; adverse event; Article; bibliographic database; cancer chemotherapy; cancer research; clinical effectiveness; clinical trial (topic); confidence interval; drug targeting; human; medical ethics; meta analysis; molecularly targeted therapy; objective response rate; oncology; overall survival; patient safety; progression free survival; publication bias; risk benefit analysis; side effect; solid malignant neoplasm; systematic review; treatment response; umbrella trial; neoplasm; oncology; personalized medicine - Pokaż więcej
- Dostawca treści:
- Repozytorium Uniwersytetu Śląskiego w Katowicach
Artykuł